Central Nervous System Smooth Muscle Tumor Linked to Epstein-Barr Virus in an HIV-Infected Individual: Challenges in Diagnosis and Treatment - Top-Institutions - MDSpire

Central Nervous System Smooth Muscle Tumor Linked to Epstein-Barr Virus in an HIV-Infected Individual: Challenges in Diagnosis and Treatment

  • By

  • Imad Majeed

  • Kenneth Schott Hannan

  • Aeron Buckley

  • Zaraq Rashid Khan

  • Faisal Rasheed

  • Lama Hanbali

  • Eyas M. Hattab

  • February 4, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - National Cancer Institute (NCI)
    National Institutes of Health (NIH) - National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Infectious Disease
    • Neuro-Oncology
    • Virology
    • Immunology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neuro-Oncology
    • Infectious Disease
    • Pathology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Disease
    • Neuro-Oncology
    • Virology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-Oncology
    • Pathology
    • Infectious Disease

  • #5

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neuro-Oncology
    • Infectious Disease
    • Immunology

Original Source(s)

Central Nervous System Smooth Muscle Tumor Linked to Epstein-Barr Virus in an HIV-Infected Individual: Challenges in Diagnosis and Treatment

  • by Imad Majeed, Kenneth Schott Hannan, Aeron Buckley, Zaraq Rashid Khan, Faisal Rasheed, Lama Hanbali, Eyas M. Hattab

  • February 4, 2026

Related Content

A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy

Hodgkin lymphoma with hypereosinophilia in a pediatric patient: case report and review of the literature

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”